BIIB800
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB800, covering 2025-10-06 to 2025-10-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants [Phase 1]